Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3000 (LINC03000)
- Target
- LINC03000
- Molecular classification
- Long non-coding RNA, Long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 3000 (LINC03000) is a member of the long intergenic non-coding RNA (lincRNA) family, a subclass of long non-coding RNAs (lncRNAs) characterized by transcripts longer than 200 nucleotides that do not overlap protein-coding genes. LincRNAs, including LINC03000, do not code for proteins but serve diverse regulatory roles, such as chromatin remodeling, transcriptional and epigenetic regulation, and RNA stabilization. While many lincRNAs have recognized roles in fine-tuning gene expression, enhancer activity, and disease (especially cancer), there is currently no published evidence that LINC03000 is a therapeutic target, directly involved in a specific disease, or that it interacts with drugs or is used as a biomarker.
- Other names
- CTC-340A15.2LOC102546299
02
Mechanism of action
None established for drugs (as LINC03000 is not a therapeutic target)
03
Biological functions
Chromatin remodelingTranscriptional regulationPotential regulation of gene expression in neighboring genesRNA stabilizationMay be involved in enhancer-associated activity (as described for lincRNAs generally)
04
Disease associations
Other (No directly documented disease association found for LINC03000 specifically; however, some lincRNAs are implicated in cancer and other diseases)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 3000 (LINC03000).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3000 (LINC03000).